U.S., Sept. 30 -- ClinicalTrials.gov registry received information related to the study (NCT07846696) titled 'An Open Label Individual Patient (OLIP)-02 Study of Nusinersen (BIIB058)' on Sept. 10.
Brief Summary: An Open Label Individual Patient (OLIP) Study of Nusinersen (BIIB058) in a Participant with Spinal Muscular Atrophy Who Previously Participated in an Investigational Study with Nusinersen
Study Start Date: Sept. 17
Study Type: INTERVENTIONAL
Condition:
SMA - Spinal Muscular Atrophy
Intervention:
DRUG: Nusinersen Injectable Product
Nusinersen intrathecal injection
Recruitment Status: NOT_YET_RECRUITING
Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Information provide...